SCHEMBL5454597

SCHEMBL5454597

COc1cccc(N(N=O)c2cccc(C(=O)O)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
NPC1 O15118 4/20 0.51
MITF O75030 1/20 0.51
MRGPRX4 Q96LA9 2/20 0.50
HSD17B2 P37059 3/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
KDM4E B2RXH2 1/20 0.46
PARP1 P09874 1/20 0.46
HSD17B1 P14061 2/20 0.46
MEP1B Q16820 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 1/20 0.45
PKM P14618 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
AKR1C3 P42330 2/20 0.44
MTNR1A P48039 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5445836 0.90 RAB9A (0.50) RAB9ANPC1MITFMRGPRX4CES2
SCHEMBL29351426 0.79 CES2 (0.74) RAB9ANPC1MITFMRGPRX4CES2
SCHEMBL63427 0.79 CES2 (0.74) RAB9ANPC1MITFMRGPRX4CES2
SCHEMBL6827745 0.79 CES2 (0.74) RAB9ANPC1MITFMRGPRX4CES2
SCHEMBL5928254 0.79 NPC1 (0.53) RAB9ANPC1MITFMRGPRX4HSD17B2
SCHEMBL5447588 0.79 PTGS1 (0.49) KDM4EAKR1C3MTNR1AMTNR1BAKR1C2
SCHEMBL5450787 0.78 ALDH1A1 (0.46) RAB9ANPC1MRGPRX4KDM4ESMN1; SMN2
SCHEMBL10403563 0.78 CES2 (0.71) RAB9ANPC1MITFMRGPRX4CES2
Hydrochloric Acid SCHEMBL30142542 0.78 CES2 (0.71) RAB9ANPC1MITFMRGPRX4CES2
SCHEMBL1448094 0.78 CES2 (0.71) RAB9ANPC1MITFMRGPRX4CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US claimed
EP-1687260-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GmbH (DE) 2006-08-09 EP claimed
WO-2005051896-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GMBH (DE) 2005-06-09 WO claimed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US disclosed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123586-A1 Nitroso derivatives of diphenylamine NOS3, CBR3, CBR1 RAB9A 3830/4885NPC1 1832/4885MITF 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.